What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
Saved in:
Main Authors: | Ivar Sonbo Kristiansen, Stein Kaasa, Christoffer Bugge, Erik Magnus Sæther, Hans Olav Melberg |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e9a4cecc7ab54a898d9af6e9d5a4fb08 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Equitable access to cancer patient pathways in Norway – a national registry-based study
by: Frank Olsen, et al.
Published: (2021) -
Norwegian physicians' knowledge of and opinions about evidence-based medicine: cross-sectional study.
by: Lidziya Vanahel Ulvenes, et al.
Published: (2009) -
Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy
by: Seung Rim Hwang, et al.
Published: (2021) -
Impacts of wild fishes attracted to open-cage salmonid farms in Norway
by: I Uglem, et al.
Published: (2014) -
I Know What you Did Last Summer
by: Bill Schindler
Published: (2013)